NCT03998969View on ClinicalTrials.gov

Efficacy of DA-5204 on Gastroesophageal Reflux Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

December 11, 2018

Study Completion Date

December 11, 2018

Conditions
Esophageal Disease
Interventions
DRUG

Pantoprazole

Pantoprazole 40mg tablet

DRUG

DA-5204

DA-5204 tablet

DRUG

Placebo

Film-coated tablet manufactured to mimic DA-5204

Trial Locations (1)

13620

Seoul National University Bungdang Hospital, Seongnam-si

All Listed Sponsors
collaborator

Dong-A ST Co., Ltd.

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT03998969 - Efficacy of DA-5204 on Gastroesophageal Reflux Disease | Biotech Hunter | Biotech Hunter